- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05628454
Comparison of Three Different Puncture Techniques in EBUS-TBNA
April 26, 2025 updated by: Beijing Friendship Hospital
The purpose of this study was to compare the accuracy and sensitivity of slow-pull capillary technique, traditional suction aspiration and non negative pressure puncture in the diagnosis of mediastinal and/or hilar lymph node enlargement by ultrasound bronchoscopic lymph node biopsy.
Study Overview
Status
Completed
Conditions
Detailed Description
EBUS-TBNA has been widely used in the diagnosis of diseases involving lung hilar and mediastinal lymph node enlargement.But different puncture methods are still controversial.
Research shows that there was no significant difference in sample adequacy, diagnostic specificity and accuracy between the no negative pressure aspiration and traditional negative pressure aspiration technique.Slow-pull capillary technique is a relatively new operating method of endoscopic ultrasound guided fine needle biopsy in recent years.
At present, this technology is widely used in pancreatic space occupying lesions.
Compared with the traditional negative pressure aspiration method, our previous retrospective study found that the slow-pull capillary technique can improve the diagnostic accuracy of patients.
Therefore, the purpose of this study is to prospectively and randomly compare the advantages and disadvantages of three puncture methods in EBUS-TBNA.
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100050
- Beijing Friendship Hospital, Capital Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-80years
- Chest computed tomography showing hilar or mediastinal lymph node enlargement
- No contraindications for bronchoscopy
- Signed informed consent provided by the patient
- Disease needs to be diagnosed through the EBUS-TBNA
Exclusion Criteria:
- Severe coagulation dysfunction
- Severe cardiopulmonary dysfunction
- Acute asthma attack or massive haemoptysis
- Poor general condition
- Physical weakness without tolerance for anaesthesia or allergy to narcotic drug
- Disease can be diagnosed by other less invasive methods (such as skin or peripheral superficial lymph node biopsy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EBUS-TBNSP
The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
|
The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
Other Names:
|
|
Experimental: EBUS-TBNA
The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
|
The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
Other Names:
|
|
Experimental: EBUS-TBNCS
The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
|
The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of three different puncture methods according to pathological diagnosis
Time Frame: 6 months
|
The final pathological diagnosis was based on all available cytological and histological samples.
In cases with negative pathological results , we continue to follow up the patients for ⩾6months.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood contamination of samples
Time Frame: 1 week
|
Blood contamination was categorized as follows: low (no or few blood cells influencing the diagnosis), moderate (sample partially obscured by blood cells, but pathological diagnosis possible), and high (large numbers of blood cells, rendering pathological diagnosis difficult)
|
1 week
|
|
Bleeding of operation
Time Frame: 1 week
|
There are three levels of bleeding:Small amount of bleeding(Ⅰ): Bleeding can stop spontaneously without continuous suction.Moderate bleeding(Ⅱ): Continuous suction is required, and epinephrine or ice salt water is used locally to stop bleeding.Massive bleeding(Ⅲ): Patients who need to be used balloon compression, interventional treatment, or blood transfusion treatment or even died of asphyxia due to bleeding.
|
1 week
|
|
Acquisition of tissue core of three different puncture methods according to the judgment of the pathologist
Time Frame: 1 week
|
Tissue cores were immersed in formalin solution and subjected to histopathological examination.
In the absence of a tissue core, the contents were pressed onto a glass slide, immersed in 96% methanol for ⩾10min and subjected to cytopathological examination.Some methods may only obtain cytological specimens, while others may obtain tissue cores.
Tissue cores are better for pathologists to diagnose.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yanjun Wu, Beijing Friendship Hospital
- Study Director: Zhigang Yao, Beijing Friendship Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 8, 2022
Primary Completion (Actual)
June 1, 2024
Study Completion (Actual)
November 1, 2024
Study Registration Dates
First Submitted
November 6, 2022
First Submitted That Met QC Criteria
November 24, 2022
First Posted (Actual)
November 28, 2022
Study Record Updates
Last Update Posted (Actual)
April 30, 2025
Last Update Submitted That Met QC Criteria
April 26, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BFH20221019005
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.